RxDoctor Payments Data

April Riggs, PA

Physician Assistant · Waynesboro, GANPI 1013978410

Payments from drug & device makers

$1,542in general payments, 2019–2025

Across 95 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$428
  • Lilly USA, LLC$277
  • Novo Nordisk$189
  • AstraZeneca$131
  • Astellas Pharma US Inc$123
  • GSK$65
  • plus $329 from 14 others

What the payments were for

  • Food & beverage$1,542100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,542 in reported general payments places this provider in the 70th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$4,393
Medicare patients
89
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide92$121,211
MounjaroTirzepatide88$104,696
JanuviaSitagliptin Phosphate72$88,911
TrulicityDulaglutide80$82,468
Trelegy ElliptaFluticasone/Umeclidin/Vilanter93$76,029
LinzessLinaclotide59$56,502
FarxigaDapagliflozin Propanediol74$56,133
EliquisApixaban50$45,068
JanumetSitagliptin Phos/Metformin Hcl16$16,200
XareltoRivaroxaban16$12,181
Tresiba Flextouch U-100Insulin Degludec22$9,738
Breo ElliptaFluticasone/Vilanterol17$7,714
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,790
Colchicine89$4,542
Lidocaine30$3,713

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$277$187,163168 claims
Novo NordiskOzempic$189$121,21192 claims
GSKTrelegy Ellipta, Breo Ellipta$65$83,743110 claims
AbbVieLinzess, Synthroid$428$57,75075 claims
AstraZenecaFarxiga$131$56,13374 claims
PfizerEliquis$12$45,06850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Waynesboro

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →